Comprehensive Perioperative Program Based on Prehabilitation, Nutritional Intervention and Psychological Support for Patients With Locally Advanced Operable Oesophagogastric Cancer (OESOFIT)
A Comprehensive Preoperative and Postoperative Program Consisting Of Active Physical Therapy, A Comprehensive Nutritional Plan, And Psychological Support For Patients With Locally Advanced, Resectable Cancer Of The Esophagus, Gastroesophageal Junction, and Stomach
研究概览
地位
详细说明
Standard care for locally advanced diseases includes perioperative chemotherapy or preoperative chemoradiotherapy, which can, in turn, lead to patient deconditioning prior to surgery. Efforts to overcome these complications led to the development of the ERAS (Enhanced Recovery After Surgery) program. This program overlaps with the emerging concept of prehabilitation/pre-optimization, which is based on identifying risk factors, formulating nutritional support, creating an exercise plan to improve overall physical fitness, and implementing continuous psychological support to enhance the patient's postoperative recovery.
The autonomic nervous system (ANS) is the body's primary homeostatic regulatory system, which can be negatively affected by anticancer treatment. Heart rate variability (HRV) is a suitable candidate for monitoring ANS function and can provide early indication of a deterioration in the sympathovagal balance of test subjects. As mentioned above, preoperative chemotherapy may further affect ANS function. It is known that regimens based on oxaliplatin and paclitaxel cause peripheral neuropathy and are associated with a significant impact on the adrenergic cardiovascular response and parasympathetic cardiac innervation. We hypothesize that a controlled increase in physical cardiorespiratory fitness during the preoperative period could improve HRV and aerobic performance, taking into account the patient's current condition. An integral part of a comprehensive program should also be perioperative individualized nutritional support aimed at maintaining body weight and muscle mass. The most common adverse effects of cancer treatment include cardiac toxicity, peripheral neuropathy, cachexia, loss of appetite, cognitive changes, fatigue, nausea, pain, and sleep disturbances, which have a significant impact on patients' quality of life. For this reason, special attention must also be paid to psychological support during active cancer treatment and in follow-up care. Psychological assessment should serve as a long-term tool for patients and families both during and after the active treatment course. Considering all the above aspects, a comprehensive assessment prior to treatment initiation and a specialized comprehensive program should be approached as a prehabilitation process. Furthermore, this concept, together with ERAS and six-month postoperative follow-up, constitutes optimal management of patients with esophageal cancer.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Martina Lojová, PhD
- 电话号码:+420543136232
- 邮箱:martina.lojova@mou.cz
研究联系人备份
- 姓名:Tereza Štěpánková, PhD
- 电话号码:+420543136223
- 邮箱:tereza.stepankova@mou.cz
学习地点
-
-
-
Brno、捷克语、65653
- 招聘中
- Masaryk Memorial Cancer Institute
-
接触:
- Martina Lojová, PhD
- 电话号码:+420543136232
- 邮箱:martina.lojova@mou.cz
-
接触:
- Tereza Štěpánková, PhD
- 电话号码:+420543136223
- 邮箱:tereza.stepankova@mou.cz
-
首席研究员:
- Radka Lordick Obermannová, Doc, MD, PhD
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Consent to participate in the study
- Age ≥ 18 years
- Patients with locally advanced esophageal or gastric cancer indicated for comprehensive perioperative treatment
- Resectable disease
- ECOG performance status 0-2
- Ability to participate in a fitness program
- Willingness to follow a nutritional plan and recommendations
Exclusion Criteria:
- Disseminated disease
学习计划
研究是如何设计的?
设计细节
- 主要用途:支持治疗
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Interventional
Participants undergo a multimodal prehabilitation and perioperative optimization program.
Intervention includes supervised home-based exercise training prescribed according to the ACSM FITT principles for 8 weeks, incorporating inspiratory muscle training initiated at 60% of baseline maximal inspiratory pressure and progressively adjusted based on perceived exertion, together with aerobic exercise at 60-80% heart rate reserve.
Training is delivered via telemedicine with regular remote supervision.
Cardiorespiratory fitness is assessed at baseline, after completion of neoadjuvant therapy, and 6 months postoperatively.
Participants will receive comprehensive nutritional assessment and individualized nutritional support, structured psychological counseling at predefined study time points, and perioperative care according to ERAS principles.
Quality of life is evaluated using validated questionnaires.
Cellular and humoral immunity and endocrine function are monitored longitudinally using
|
A single measurement before the start of preoperative treatment (baseline), after completion of chemotherapy 4-2 weeks before surgery, and 6 months after surgery.
Exercise training is prescribed in accordance with the guidelines for prescribing physical activity (the FITT methodology published by the ACSM in 2018) for a period of 2 months.
Training is set at 60% of the baseline maximum inspiratory pressure (MIP) and is increased by 5% if the participant reports a rate of perceived exertion (RPE) < 7 (RPE scale 1-10).
Exercises is conducted under supervision using telemedicine technologies.
Weekly online check-ins via video call using the MOU MEDDI platform (first 4 weeks), then once every 14 days.
Alternatively, weekly training sessions at the gym for the first 4 weeks (3 times a week at home, walking for at least 30 minutes per training session), followed by independent training at home.
The intensity of aerobic training is prescribed based on a target heart rate of 60-80% of the heart rate reserve.
An important part of the evaluation is also the patient's adherence to the exercise intervention and their level of physical activity.
Psychological intervention is provided to each patient at the following time points: 1) upon enrollment in the study, 2) before surgery, 3) 30 days after surgery, and 4) 6 months after surgery.
It is assessed using standardized questionnaires.
Monitoring of cellular and humoral immunity/endocrine function will be performed by flow cytometry using two peripheral blood samples (1 tube containing 2.7 mL of EDTA-anticoagulated blood and 1 tube containing 5 mL of anticoagulant-free blood for serum separation) at 4 time points: 1) upon study enrollment, 2) before surgery, 3) 30 days after surgery, and 4) 6 months after surgery.
Multicolor (6 to 8 colors) protocols for the proposed immune profile have already been established.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change From Baseline in Autonomic Nervous System Balance as Measured by Heart Rate Variability
大体时间:Baseline (pre-intervention), Perioperative, 1 year
|
Evaluation of the root mean square of successive differences in milliseconds between heartbeats to assess parasympathetic activity.
|
Baseline (pre-intervention), Perioperative, 1 year
|
|
Change From Baseline in Sleep Quality as Measured by the Pittsburgh Sleep Quality Index
大体时间:Baseline (pre-intervention), Perioperative, 1 year
|
Total score on the Pittsburgh Sleep Quality Index questionnaire (range 0-21), where higher scores indicate poorer sleep quality
|
Baseline (pre-intervention), Perioperative, 1 year
|
|
Change From Baseline in Health-Related Quality of Life as Measured by the EORTC QLQ-C30 Questionnaire
大体时间:Baseline (pre-intervention), Perioperative, 1 year
|
Global health status/Quality of life scale score (range 0-100) from the European Organisation for Research and Treatment of Cancer core questionnaire
|
Baseline (pre-intervention), Perioperative, 1 year
|
|
Change From Baseline in Fatigue Severity as Measured by the Functional Assessment of Chronic Illness Therapy - Fatigue Scale
大体时间:Baseline (pre-intervention), Perioperative, 1 year
|
Total score on the 13-item fatigue subscale (range 0-52), where lower scores indicate higher levels of fatigue.
|
Baseline (pre-intervention), Perioperative, 1 year
|
|
Change From Baseline in Cardiorespiratory Fitness as Measured by Peak Oxygen Consumption (VO2 peak)
大体时间:Baseline (pre-intervention), 1 year
|
Peak oxygen uptake measured in ml/kg/min during a cardiopulmonary exercise test on a cycle ergometer.
|
Baseline (pre-intervention), 1 year
|
|
Change From Baseline in Muscle Strength as Measured by Handgrip Dynamometry
大体时间:Baseline (pre-intervention), Perioperative, 1 year
|
Maximum grip strength measured in kilograms (kg) using a calibrated handheld dynamometer.
|
Baseline (pre-intervention), Perioperative, 1 year
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Incidence of Postoperative Respiratory Complications
大体时间:Perioperative
|
Percentage of participants experiencing respiratory complications (e.g., pneumonia, respiratory failure) as defined by the Clavien-Dindo classification (Grade II or higher).
|
Perioperative
|
|
Incidence of Anastomotic Dehiscence
大体时间:Perioperative
|
Percentage of participants with radiologically or clinically confirmed leakage at the site of surgical anastomosis.
|
Perioperative
|
|
Change From Baseline in Daily Physical Activity Level as Measured by Average Daily Step Count
大体时间:Baseline (pre-intervention), Perioperative, 1 year
|
Average number of steps per day recorded by a digital pedometer/accelerometer.
|
Baseline (pre-intervention), Perioperative, 1 year
|
|
Change From Baseline in Lean Body Mass as Measured by Bioelectrical Impedance Analysis
大体时间:Baseline (pre-intervention), Perioperative, 1 year
|
Total lean body mass measured in kilograms (kg) using a multi-frequency Bioelectrical Impedance Analysis device.
|
Baseline (pre-intervention), Perioperative, 1 year
|
|
Change From Baseline in Nutritional Intake (Protein Intake)
大体时间:Baseline (pre-intervention), Perioperative, 1 year
|
Daily protein intake measured in grams per kilogram of body weight (g/kg/day) based on a 3-day food record.
|
Baseline (pre-intervention), Perioperative, 1 year
|
|
Change From Baseline in Psychological Distress as Measured by the Hospital Anxiety and Depression Scale
大体时间:Baseline (pre-intervention), Perioperative, 1 year
|
Total score for anxiety and depression subscales (each range 0-21) to evaluate the impact of psychological support.
|
Baseline (pre-intervention), Perioperative, 1 year
|
合作者和调查者
调查人员
- 首席研究员:Radka Lordick Obermannová, Doc, MD, PhD、Masaryk Memorial Cancer Institute
出版物和有用的链接
一般刊物
- https://doi.org/10.1007/PL00007853
- Kawata S, Hiramatsu Y, Shirai Y, Watanabe K, Nagafusa T, Matsumoto T, Kikuchi H, Kamiya K, Takeuchi H. Multidisciplinary team management for prevention of pneumonia and long-term weight loss after esophagectomy: a single-center retrospective study. Esophagus. 2020 Jul;17(3):270-278. doi: 10.1007/s10388-020-00721-0. Epub 2020 Feb 6.
- 10.23736/S0393-3660.18.03986-4
- Adams SC, Schondorf R, Benoit J, Kilgour RD. Impact of cancer and chemotherapy on autonomic nervous system function and cardiovascular reactivity in young adults with cancer: a case-controlled feasibility study. BMC Cancer. 2015 May 18;15:414. doi: 10.1186/s12885-015-1418-3.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- A12/23
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
IPD 共享时间框架
IPD 共享访问标准
During the study, data will be managed in pseudonymized form in a protected database environment, available only for study team.
After completion of the study, the data will be fully anonymized for publication purposes. All publication outputs of the study will be carried out by a team of researchers led by the principal investigator. The submission of each publication is subject to the approval of the principal investigator.
The results of this study may be published or presented at scientific meetings after approval by the PI and always after anonymization of the subjects' personal data in accordance with Act No. 101/2000 Coll., on the protection of personal data.
IPD 共享支持信息类型
- 企业社会责任
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.